Isabel Chirivella

OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study

Christophe Tournigand, Andrés Cervantes, Arié Figer et al. · Journal of Clinical Oncology · 2006 · 799 citations

Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients

Isabel Chirivella, Begoña Bermejo, Amelia Insa et al. · Breast Cancer Research and Treatment · 2008 · 172 citations · Full text

Reintroduction of Oxaliplatin Is Associated With Improved Survival in Advanced Colorectal Cancer

Aimery de Gramont, Marc Buyse, José Cortiñas Abrahantes et al. · Journal of Clinical Oncology · 2007 · 132 citations

Phase I Safety, Pharmacokinetics, and Inhibition of Src Activity Study of Saracatinib in Patients with Solid Tumors

José Baselga, Andrés Cervantes, Erika Martinelli et al. · Clinical Cancer Research · 2010 · 108 citations

The Average Cumulative Risks of Breast and Ovarian Cancer for Carriers of Mutations in <i>BRCA1</i> and <i>BRCA2</i> Attending Genetic Counseling Units in Spain

Roger L. Milne, Ana Osório, Teresa Ramón y Cajal et al. · Clinical Cancer Research · 2008 · 93 citations · Full text